Companies: 10,795·Total market cap: $144.5T
Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc.

NRIXNASDAQHealthcare● Active
$15.84
+$1.20(+8.20%)
Market Cap$1.4B
P/E Ratio
52W High$22.5
52W Low$8.195
Overview

Nurix Therapeutics, Inc. (NRIX) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

nrix · stock forecast · 17 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 17 Wall Street analysts in the past 3 months

SellBuy

Buy

17 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
17
Hold
0
Sell
0
Strong Sell
0
Total: 17 · Buy rate: 100.0%

12-Month Price Target

High

$36.00

Consensus

$32.20

+102.8% upside

Low

$28.00

Median: $32 · Last Close: $15.88

The Nurix Therapeutics, Inc. (NRIX) analyst consensus is Buy, based on ratings from 17 Wall Street analysts over the past 3 months. The average 12-month NRIX price target is $32.20, representing +102.8% upside from the current price of $15.88.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $32 (102.8%)

Consensus Target

$32.20

102.8% upside

High Target

$36

126.8%

Low Target

$28

76.4%

Current Price

$15.88

as of today

Based on analyst price targets, the NRIX stock price prediction for the next 12 months ranges from $28 to $36. The consensus NRIX price forecast of $32.20 implies 102.8% upside from the current price of $15.88.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$15.293.71%

1-day model range: $15.19–$15.38. Peak: $15.38 (-3.71%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$15-7.9%
2028$14-11.8%
2029$14-13.9%
2030$13-15.1%
2031-15.7%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

29%7%64%
4Buy
1Neutral
9Sell
RSI (14)52.5Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · NRIX · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$15.53BUY
MA 10$16.53SELL
MA 20$16.39SELL
MA 50$16.35SELL
MA 100$16.37SELL
MA 200$14.79BUY
Current $NRIX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$15.71BUY
EMA 10$16.09SELL
EMA 20$16.33SELL
EMA 50$16.34SELL
EMA 100$16.11SELL
EMA 200$15.51BUY
Current $NRIX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
BTIG2026-05-18
Maintains
BuyBuy
HC Wainwright & Co.2026-04-27
Maintains
BuyBuy
Needham2026-04-23
Maintains
BuyBuy
HC Wainwright & Co.2026-04-10
Maintains
BuyBuy
Wells Fargo2026-04-09
Maintains
OverweightOverweight
Needham2026-04-08
Maintains
BuyBuy
HC Wainwright & Co.2026-03-24
Maintains
BuyBuy
Needham2026-01-29
Maintains
BuyBuy
RBC Capital2026-01-29
Maintains
OutperformOutperform
Wells Fargo2026-01-29
Maintains
OverweightOverweight

Wall Street analysts have recently issued updated ratings on Nurix Therapeutics, Inc. (NRIX) stock. Of the recent 127 rating actions, 2 were upgrades and 0 were downgrades. 17 analysts currently cover NRIX.

Analyst Recommendation Trends

Buy ratings211
Hold ratings00
Sell ratings00

NRIX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$56M

↓ 57.3% YoY

Revenue Next Year

$74M

↑ 33.5% YoY

EPS This Year

$-2.97

EPS Next Year

$-2.85

↓ 3.9% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast NRIX EPS of $-2.97 for the current fiscal year, based on estimates from 13 analysts. The NRIX revenue forecast is $56M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The NRIX stock forecast is supported by two independent data sources: analyst consensus ratings from 17 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus NRIX price target is $32.20 (+102.8% upside), with an analyst consensus of Buy.

The NRIX short-term stock prediction for tomorrow is $15.29 (-3.71%). The NRIX stock price prediction for 2027 estimates an average of $15. The NRIX stock prediction for 2030 projects a range of $13–$14.

Nurix Therapeutics, Inc. trades on NASDAQ under the ticker NRIX. The NRIX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

NRIX forecast · 8 questions

According to 17 Wall Street analysts, the average 12-month NRIX price target is $32.20, with a high forecast of $36.00 and a low of $28.00. The median price target is shown in the chart above when available. This implies +102.8% potential upside from the current price of $15.88.

NRIX price targetWhat is NRIX price targetNRIX analyst price targetNRIX 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.